Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Artificial intelligence has shifted from futuristic idea to everyday assistant for real estate professionals. Instead of replacing agents, AI now enhances their workflows—automating repetitive tasks, improving communication, strengthening branding, and turning complex market data into clear insights. From smarter CRMs to AI-powered marketing tools, today’s agents can focus more on relationships and client service while technology handles the busywork behind the scenes.
A Florida House committee is advancing a bill that would crack down on insurers shifting profits to affiliated companies — a practice highlighted by recent investigative reporting. With premiums soaring and options shrinking, the proposed oversight could reshape the state’s insurance landscape and create ripple effects across the real estate market, impacting buyers, agents, and investors statewide.
Proptech podcast *Tangent* marks its 100th episode with an inside look at Airbnb’s evolving role in multifamily housing. Featuring Airbnb Real Estate Marketing Leader Eliza Lochner, the episode explores the rapid growth of Airbnb‑friendly apartments, the rise of flexible‑living models, and why renters and property owners are increasingly embracing hosting as a way to balance affordability, transparency, and control. For today’s real estate professionals—especially in fast‑changing markets like Florida—the conversation highlights major shifts in tenant expectations, property management strategies, and the intersection of technology, hospitality, and residential development.
A Tampa Heights homeowner has joined the growing wave of Floridians dropping property insurance altogether after his 2026 renewal skyrocketed to $14,523. With up to 20% of residents now going bare, experts warn that soaring rates, shrinking coverage options, and post‑storm losses are pushing many to take risky measures — even as alternatives like liability‑only plans, dropped wind coverage, or home‑hardening upgrades may offer relief.
A major ERAS overhaul is coming in 2027, replacing the familiar “publications” field with a more rigorous category called “scholarly works.” Only peer‑reviewed submissions—such as manuscripts, abstracts, book chapters, and presentations—will qualify, shifting greater emphasis toward high‑quality research. While the change aims to give residency directors clearer insight into applicants’ academic contributions, many students worry that advocacy and policy work may lose visibility. As programs lean more heavily on research output in a post–Step 1 pass/fail era, future applicants will need to showcase not just what they’ve produced, but the depth and meaning behind it.
Mortgage rates have ticked back up to 6.25% after a brief dip, signaling a return to stability in the housing market. With rising inventory, moderating prices, and forecasts calling for steady rates through 2026, real estate and finance professionals can expect a more predictable environment ahead. This shift opens the door to smoother transactions, improved buyer confidence, and stronger opportunities for career growth across mortgage, real estate, insurance, and related fields.
